Report Overview

Increasing implementation of artificial intelligence in diabetes care devices and rising number of diabetes patients are projected to propel the expansion of India insulin pumps market during the forecast period between 2023 and 2029.

India Insulin Pumps Market - Industry Trends & Forecast Report, 2029

India insulin pumps market size was estimated at USD 13.28 million in 2022. During the forecast period between 2023 and 2029, the size of India insulin pumps market is projected to grow at CAGR of 9.95% reaching a value of USD 25.55 million by 2029. Major growth drivers for India insulin pumps market include increasing prevalence of diabetes in the country and increasing awareness of the benefits of insulin pump therapy among both patients and healthcare professionals. Insulin pumps offer a number of advantages over traditional insulin injection therapy, including more precise dosing and the ability to continuously monitor blood glucose levels. As awareness of these benefits grows, more patients are expected to adopt insulin pump therapy. According to the International Diabetes Federation, India has the second-highest number of people with diabetes in the world, after China. In 2021, it was estimated over 74 million adults in India had diabetes. Also, the India Insulin Pumps Market is highly competitive, with a number of international and domestic players competing for market share. This is expected to drive innovation and improve access to insulin pump therapy for patients in India.

India Insulin Pumps Market – Overview

India insulin pumps market refers to the market for medical devices that are used to deliver insulin to people with diabetes. Insulin pumps are small, computerized devices that are worn on the body and deliver insulin continuously throughout the day, according to a programmed schedule. They are an alternative to traditional insulin injection therapy, which involves injecting insulin into the body using a syringe or pen. The India insulin pumps market includes both insulin pump devices and associated accessories, such as infusion sets and reservoirs. The market is primarily driven by the increasing prevalence of diabetes in India and the growing awareness of the benefits of insulin pump therapy among both patients and healthcare professionals. The demand for insulin pumps in India differs widely across regions, mainly influenced by factors such as the prevalence of diabetes, awareness levels, receptiveness to new treatment approaches, and affordability. Kerala, Chandigarh, and Tamil Nadu are some of the states with the highest prevalence of diabetes cases. According to studies, the incidence of Type 1 diabetes is rising at a rate of approximately 3-5% per year. While Type 1 diabetes is largely hereditary, it can also be triggered by an autoimmune response to viruses or the environment. Insulin pumps are also frequently utilized by people diagnosed with Type 2 diabetes in India.

India Insulin Pumps Market

Growth Drivers

Advent of Artificial Intelligence in Diabetes Care Devices

The advent of Artificial Intelligence (AI) in diabetes care devices is expected to have a significant impact on the expansion of the India insulin pumps market. AI technology is being used to develop insulin pumps that can automatically adjust insulin delivery based on real-time blood glucose readings, thereby providing more precise and personalized insulin therapy. One of the key benefits of AI-powered insulin pumps is that they can help to reduce the risk of hypoglycemia, a potentially dangerous condition that can occur when blood glucose levels drop too low. By continuously monitoring glucose levels and adjusting insulin delivery in real-time, these devices can help to maintain glucose levels within a safe range and minimize the risk of hypoglycemia. Another benefit of AI-powered insulin pumps is that they can help to simplify diabetes management for patients. With these devices, patients no longer need to manually calculate insulin dosages or adjust their therapy based on changes in diet or physical activity. Instead, the insulin pump can take care of these tasks automatically, freeing up time and mental energy for patients to focus on other aspects of their lives. The development of AI-powered insulin pumps is still in the early stages, but several companies are already working on bringing these devices to market.

Restraints

High Cost of Devices

The high cost of insulin pumps is indeed one of the factors that may impede the growth of the India insulin pumps market. Insulin pumps are generally more expensive than traditional insulin injection therapy, and this can make them unaffordable for some patients. In addition, the cost of consumables such as infusion sets and reservoirs can also add up over time. This cost barrier is particularly significant in a country like India, where a large proportion of the population lives in poverty and has limited access to healthcare. Many patients with diabetes in India may not be able to afford insulin pump therapy, even if it is recommended by their healthcare provider.

Impact of COVID-19 on India Insulin Pumps Market

COVID-19 pandemic had a dual impact on the India insulin pumps market. The disruptions in supply chains, reduced access to healthcare facilities, and economic uncertainty caused by the pandemic have negatively impacted the market. Shortages of insulin pumps and other diabetes care products have arisen due to import restrictions, leading to affected patient access to the devices. Additionally, reduced access to healthcare facilities has made it challenging for patients with diabetes to receive the necessary care, including insulin pump therapy. Conversely, the pandemic has raised awareness of managing chronic conditions such as diabetes, potentially driving demand for insulin pumps. To ensure patients have access to the care and devices they need, it is essential for stakeholders in the market to adapt to the evolving pandemic conditions.

India Insulin Pumps Market

Segmental Coverage

India Insulin Pumps Market – By Type

By type, India insulin pumps market is split into Patch Pumps and Tethered Pumps segments. The patch pump segment holds a higher share in the India insulin pumps market, as patch pumps are more convenient and discreet than other types of insulin pumps, making them a popular choice among patients. The patch pumps are small, lightweight, and attach directly to the skin, making them easy to wear and carry around. Additionally, patch pumps offer the same benefits as traditional insulin pumps, such as precise insulin delivery, customizable dosing, and the ability to track blood glucose levels. They also do not require frequent insertion and removal of infusion sets, which can be a significant advantage for patients who find this process uncomfortable or inconvenient.

India Insulin Pumps Market – By Accessories

Based on accessories, India insulin pumps market is divided into Insulin reservoir or cartridges, Insulin Set Insertion Devices, and Battery segments. In 2020, the insulin set insertion devices segment was the most dominant in the market. The primary reason for the segment's high market share is the frequency of use, as general infusion sets of insulin pumps need to be changed every two to three days. Additionally, the high cost of infusion sets is another contributing factor. During the forecast period, the insulin reservoir or cartridges segment is expected to experience significant growth. The growth of this segment is mainly driven by the increasing adoption of tethered pumps, which involve loading a cartridge of insulin into the reservoir or drawing insulin from a vial into the reservoir. These reservoirs can hold up to 300 units of insulin and do not require frequent changes, typically lasting 2-3 days. These factors are expected to be major growth drivers for the insulin reservoir or cartridges segment.

India Insulin Pumps Market – By End Use

Based on end use, India insulin pumps market is divided into Hospitals & Clinics, Homecare, and Laboratories segments. The hospitals and clinics segment held the highest market share in 2020 and projected to maintain its dominance over the forecast period. The significant market share of this segment can be attributed to several factors, such as the presence of skilled healthcare professionals, increasing government funding, and rising private sector investment in the healthcare sector. The homecare segment is expected to dominate the market during the forecast period. This growth can be attributed to the increasing awareness of insulin pump usage and the high adoption of these products in the home setting due to their ease of use. Additionally, the usage of patch pumps, which are small in size and easy to carry, is expected to further drive market growth during the forecast period.

India Insulin Pumps Market – By Region

Based on region, the report India insulin pumps market covers North India, South India, East India, and West India. The South India region of India holds a notable portion of the insulin pumps market due to the high general awareness of diabetes and the growing number of cases. Furthermore, there is a greater penetration of affordable insulin pumps produced in India, which are considerably less expensive than imported options. In the western region of India, there is a trend of developing technologically advanced pumps that can be conveniently used from the comfort of one's home. This region also has a strong presence of key players in the industry, such as Medtronic.

Competitive Landscape

Major players operating in India insulin pumps market include Medtronic plc, Hoffmann-La Roche Ltd, Tandem Diabetic Care, Inc., Insulet Corporation, Ypsomed, Cellenovo, Sooil Development, Valeritas, Inc, and JingasuDelfu Co., Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

• In August 2022 - Insulet Corporation received FDA approval for the use of their tubeless insulin pumps in children aged 2 years or older with type 1 diabetes, which is a positive sign for the India insulin pumps market as it suggests the possibility of approval for use within India as well.

• In August 2022 – the FDA approved Omnipod 5, an automated insulin delivery system that can be controlled via smartphone without the need for a separate controller unit. This system was fully launched for children aged 6 years and above.

• In July 2022 - Thiruvananthapuram-based diabetes forum 'Jothydev's Professional Education Forum (JPEF)' identified that 95% of life-saving technologies, such as advanced patch insulin pumps and tandem, that are available in western countries, are not yet available in India. The forum has highlighted these technologies for further discussion, and it is likely that they will soon enter the Indian market, which will drive demand for the India insulin pumps market.

• In March 2022 - Medtronic India launched the MiniMed 780G system for diabetes management, which is a closed loop insulin pump system used to treat type 1 diabetes in people of all ages. This system can connect to smartphones via Bluetooth, allowing patients to check their glucose levels on their phones via apps.

Scope of the Report

By Type

• Patch Pumps

• Tethered Pumps

By Accessories

• Insulin Reservoir or Cartridges

• Insulin Set Insertion Devices

• Battery

By End Use

• Hospitals & Clinics

• Homecare

• Laboratories

By Region

• North India

• South India

• East India

• West India